Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2021

Open Access 01-12-2021 | Metastasis | Research article

Cardiovascular characteristics of patients initially diagnosed breast cancer

Authors: Zhaoying Dong, Fan Zhang, Qiaojuan Huang, Zhaojun Liu, Siyu Chen, Tao Xu, Jun Xiao, Changhong Zhang, Xiaoli Zhou

Published in: Journal of Cardiothoracic Surgery | Issue 1/2021

Login to get access

Abstract

Objective

We aimed to explore the cardiovascular characteristics of patients who were initially diagnosed with breast cancer.

Methods

A total of 600 patients who were diagnosed with primary breast cancer were included in this retrospective study. The data of fasting blood glucose, total cholesterol, total triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, lipoprotein (a) (LP (a)) and serum uric acid were collected. Univariate analysis was used to evaluate the cardiovascular risk factors (CVRFs) in patients with breast cancer. The arteriosclerotic cardiovascular disease (ASCVD) risk assessment was performed. Multivariate analysis was used to identify the factors that influenced axillary lymph node metastasis (ALNM).

Results

Compared with the premenopausal group, the prevalence of overweight/obesity (47.6% vs. 35.2%), diabetes (12.8% vs. 4.3%) and hypertension (49.7% vs. 26.3%) were significantly increased in the postmenopausal group (p < 0.05). Comparisons of rural patients and urban patients showed that there were significant differences in the diagnostic age (49.94 ± 9.92 vs. 52.59 ± 11.13) in the rural patients was notably younger in comparison with the urban patients (p < 0.05). However, the number of menopausal patients (44.3% vs. 53.3%) in the rural group were decreased in comparison with the urban group (p < 0.05). In ASCVD risk stratification, the proportion of low-risk patients (56.4% vs. 90.8%), medium-risk patients (20.6% vs 0.3%) and high-risk patients (19.3% vs. 6.6%) were significantly different between the postmenopausal group and premenopausal group (p < 0.05). Residence (OR 0.735; 95% CI 0.516–1.046; p = 0.087), the number of children (OR 1.250; 95% CI 0.990–1.578; p = 0.061) and LP (a) of ≥ 500 mg/L (OR 0.603; 95% CI 0.342–1.063; p = 0.080) were independent influencing factors of ALNM.

Conclusion

Postmenopausal patients have more CVRFs and higher risks of ASCVD than premenopausal patients initially diagnosed with breast cancer. There was a correlation between CVRFs and ALNM in patients with breast cancer.
Literature
1.
go back to reference Therapy CEGoMMoDiBCPwE. China expert consensus on the management of dyslipidemia in postmenopausal patients with early-stage breast cancer. Chin J Oncol. 2017;39:72–7. Therapy CEGoMMoDiBCPwE. China expert consensus on the management of dyslipidemia in postmenopausal patients with early-stage breast cancer. Chin J Oncol. 2017;39:72–7.
2.
go back to reference Ying Z, Chun-Xiao WU, Minlu Z. The epidemic and characteristics of female breast cancer in China. China Oncol. 2013;23:561–9. Ying Z, Chun-Xiao WU, Minlu Z. The epidemic and characteristics of female breast cancer in China. China Oncol. 2013;23:561–9.
3.
go back to reference Chan DS, Norat T. Obesity and breast cancer: not only a risk factor of the disease. Curr Treat Opt Oncol. 2015;16:22.CrossRef Chan DS, Norat T. Obesity and breast cancer: not only a risk factor of the disease. Curr Treat Opt Oncol. 2015;16:22.CrossRef
4.
go back to reference Tamirisa N, Lin H, Shen Y, Shaitelman SF, Sri Karuturi M, Giordano SH, et al. Association of chemotherapy with survival in elderly patients with multiple comorbidities and estrogen receptor-positive. Node Positive Breast Cancer JAMA Oncol. 2020;6(10):1548–54.PubMed Tamirisa N, Lin H, Shen Y, Shaitelman SF, Sri Karuturi M, Giordano SH, et al. Association of chemotherapy with survival in elderly patients with multiple comorbidities and estrogen receptor-positive. Node Positive Breast Cancer JAMA Oncol. 2020;6(10):1548–54.PubMed
5.
go back to reference Rodriguez LA, Bradshaw PT, Parada H, Khankari NK, Wang T, Cleveland RJ, et al. Diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer. Cancer Causes Control. 2020;31(5):517–24.CrossRef Rodriguez LA, Bradshaw PT, Parada H, Khankari NK, Wang T, Cleveland RJ, et al. Diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer. Cancer Causes Control. 2020;31(5):517–24.CrossRef
6.
go back to reference Knisely JPS, Henry SA, Saba SG, Puckett LL. Cancer and cardiovascular disease. Lancet. 2020;395(10241):1904.CrossRef Knisely JPS, Henry SA, Saba SG, Puckett LL. Cancer and cardiovascular disease. Lancet. 2020;395(10241):1904.CrossRef
7.
go back to reference Harake D, Franco Vi Fau-Henkel JM, Henkel Jm Fau-Miller TL, Miller Tl Fau-Lipshultz SE, Lipshultz SE. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol. 2012;8:647–70. Harake D, Franco Vi Fau-Henkel JM, Henkel Jm Fau-Miller TL, Miller Tl Fau-Lipshultz SE, Lipshultz SE. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol. 2012;8:647–70.
8.
go back to reference Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgrad Med J. 2017;93:82–90. Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgrad Med J. 2017;93:82–90.
9.
go back to reference King H. WHO and the International Diabetes Federation: regional partners. Bull World Health Organ. 1999;77:954. King H. WHO and the International Diabetes Federation: regional partners. Bull World Health Organ. 1999;77:954.
10.
go back to reference Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.CrossRef Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.CrossRef
11.
go back to reference Zhu JR, Zhao S, Zhao D, Li J. Guidelines for the prevention and treatment of dyslipidemia in Chinese adults (2016 Revision). Chin Circ J. 2016;16:15–35. Zhu JR, Zhao S, Zhao D, Li J. Guidelines for the prevention and treatment of dyslipidemia in Chinese adults (2016 Revision). Chin Circ J. 2016;16:15–35.
12.
go back to reference Chinese Endocrine Society. Guidelines for the diagnosis and treatment of hyperuricemia and gout in China (2019). Chin J Endocrinol Metab. 2020;1:1–13. Chinese Endocrine Society. Guidelines for the diagnosis and treatment of hyperuricemia and gout in China (2019). Chin J Endocrinol Metab. 2020;1:1–13.
13.
go back to reference Wgooi C. Guidelines for the prevention and control of overweight and obesity in Chinese adults (excerpts). Acta Nutrimenta Sinca. 2004;26:1–4. Wgooi C. Guidelines for the prevention and control of overweight and obesity in Chinese adults (excerpts). Acta Nutrimenta Sinca. 2004;26:1–4.
14.
go back to reference Catapano Al Fau-Graham I, Graham I Fau-De Backer G, De Backer G Fau-Wiklund O, Wiklund O Fau-Chapman MJ, Chapman Mj Fau-Drexel H, Drexel H Fau-Hoes AW, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058. Catapano Al Fau-Graham I, Graham I Fau-De Backer G, De Backer G Fau-Wiklund O, Wiklund O Fau-Chapman MJ, Chapman Mj Fau-Drexel H, Drexel H Fau-Hoes AW, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058.
15.
go back to reference Qi Y. 2018 Chinese guideline on menopause management and menopause hormone therapy. Med J Peking Union Med Coll Hosp. 2018;9:512–25. Qi Y. 2018 Chinese guideline on menopause management and menopause hormone therapy. Med J Peking Union Med Coll Hosp. 2018;9:512–25.
16.
go back to reference Gernaat SAM, Ho PJ, Rijnberg N, Emaus MJ, Baak LM, Hartman M, et al. Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164:537–55.CrossRef Gernaat SAM, Ho PJ, Rijnberg N, Emaus MJ, Baak LM, Hartman M, et al. Risk of death from cardiovascular disease following breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164:537–55.CrossRef
17.
go back to reference Hooning MJ, Aleman BM, van Rosmalen AJ, Kuenen MA, Klijn JG, van Leeuwen FE. Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64:1081–91.CrossRef Hooning MJ, Aleman BM, van Rosmalen AJ, Kuenen MA, Klijn JG, van Leeuwen FE. Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64:1081–91.CrossRef
18.
go back to reference Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34:1122–30.CrossRef Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34:1122–30.CrossRef
19.
go back to reference Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women's health initiative randomized clinical trials. JAMA Oncol. 2015;1:611–21. Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women's health initiative randomized clinical trials. JAMA Oncol. 2015;1:611–21.
20.
go back to reference Papa V, Pezzino V Fau-Costantino A, Costantino A Fau-Belfiore A, Belfiore A Fau-Giuffrida D, Giuffrida D Fau-Frittitta L, Frittitta L Fau-Vannelli GB, et al. Elevated insulin receptor content in human breast cancer. J Clin Invest. 1990;86:1503–10. Papa V, Pezzino V Fau-Costantino A, Costantino A Fau-Belfiore A, Belfiore A Fau-Giuffrida D, Giuffrida D Fau-Frittitta L, Frittitta L Fau-Vannelli GB, et al. Elevated insulin receptor content in human breast cancer. J Clin Invest. 1990;86:1503–10.
21.
go back to reference Ward CW, Lawrence MC. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays. 2009;31:422–34. Ward CW, Lawrence MC. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays. 2009;31:422–34.
22.
go back to reference Zhao S Fau-Chlebowski RT, Chlebowski Rt Fau-Anderson GL, Anderson Gl Fau-Kuller LH, Kuller Lh Fau-Manson JE, Manson Je Fau-Gass M, Gass M Fau-Patterson R, et al. Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast Cancer Res. 2014;26;16(2):R30. Zhao S Fau-Chlebowski RT, Chlebowski Rt Fau-Anderson GL, Anderson Gl Fau-Kuller LH, Kuller Lh Fau-Manson JE, Manson Je Fau-Gass M, Gass M Fau-Patterson R, et al. Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast Cancer Res. 2014;26;16(2):R30.
23.
go back to reference Shengshou GR, Liu L, Zhu M, Wang W, Wang Y, Wu Z, Li H, Gu D, Yang Y, Zheng Z, Chen W. Summary of China’s cardiovascular report 2018. Chin Circ J. 2019;34:6–17. Shengshou GR, Liu L, Zhu M, Wang W, Wang Y, Wu Z, Li H, Gu D, Yang Y, Zheng Z, Chen W. Summary of China’s cardiovascular report 2018. Chin Circ J. 2019;34:6–17.
24.
go back to reference Balkwill F, Charles Ka Fau-Mantovani A, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211–7. Balkwill F, Charles Ka Fau-Mantovani A, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211–7.
25.
go back to reference Hamet P. Cancer and hypertension. An unresolved issue. Hypertension. 1996;28:321–4.CrossRef Hamet P. Cancer and hypertension. An unresolved issue. Hypertension. 1996;28:321–4.CrossRef
26.
go back to reference Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens. 2006;20:727–32. Largent JA, McEligot AJ, Ziogas A, Reid C, Hess J, Leighton N, Peel D, Anton-Culver H. Hypertension, diuretics and breast cancer risk. J Hum Hypertens. 2006;20:727–32.
27.
go back to reference Noh HM, Song YM, Park JH, Kim BK, Choi YH. Metabolic factors and breast cancer risk in Korean women. Cancer Causes Control. 2013;24:1061–8.CrossRef Noh HM, Song YM, Park JH, Kim BK, Choi YH. Metabolic factors and breast cancer risk in Korean women. Cancer Causes Control. 2013;24:1061–8.CrossRef
28.
go back to reference Gong WLS, Hu R, Wang H, Pan J, Fei F, He Q, Yu M. Analysis of survival rate of breast, cervical, and ovarian cancer patients during 2005–2010 in Zhejiang province, China. Chin J Prevent Med. 2014;48:366–9. Gong WLS, Hu R, Wang H, Pan J, Fei F, He Q, Yu M. Analysis of survival rate of breast, cervical, and ovarian cancer patients during 2005–2010 in Zhejiang province, China. Chin J Prevent Med. 2014;48:366–9.
29.
go back to reference Wang SWY, Rong T. Reproductive history and prognosis in patients with operable breast cancer. Tumor. 1999;19:75–7.CrossRef Wang SWY, Rong T. Reproductive history and prognosis in patients with operable breast cancer. Tumor. 1999;19:75–7.CrossRef
30.
go back to reference Sharma AGB, Gupta N, Chakraborty B. Lipoprotein (a) plasma levels and risk of breast cancer. Hellenic J Surg. 2015;87:298–302.CrossRef Sharma AGB, Gupta N, Chakraborty B. Lipoprotein (a) plasma levels and risk of breast cancer. Hellenic J Surg. 2015;87:298–302.CrossRef
31.
go back to reference Katzke VASD, Johnson T, Kühn T, Kaaks R. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC–Heidelberg cohort. BMC Med. 2017;15:218.CrossRef Katzke VASD, Johnson T, Kühn T, Kaaks R. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC–Heidelberg cohort. BMC Med. 2017;15:218.CrossRef
Metadata
Title
Cardiovascular characteristics of patients initially diagnosed breast cancer
Authors
Zhaoying Dong
Fan Zhang
Qiaojuan Huang
Zhaojun Liu
Siyu Chen
Tao Xu
Jun Xiao
Changhong Zhang
Xiaoli Zhou
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2021
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-021-01608-6

Other articles of this Issue 1/2021

Journal of Cardiothoracic Surgery 1/2021 Go to the issue